GD
Gillian Dilallo
Credentials: ·
History
- 2018–2021
Residency
2014–2018
Research
Giredestrant plus Everolimus in Advanced Breast Cancer
New England Journal of Medicine · 2026
- AB
1 paper
- AF
1 paper
1 paper
1 paper
1 paper
- KJ
1 paper
- MK
1 paper
1 paper
